Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal nalbuphine as adjuvant to bupivacaine vs bupivacaine alone in unilateral total knee arthroplasty
TCTR20250108002Phase 2Recruiting
- Sponsor
- Vajira Hospital
- Start
- Oct 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in knee osteoarthritis (OA) comparing Intrathecal nalbuphine + bupivacaine with Intrathecal bupivacaine alone (2 arms). Started Oct 2024; status: recruiting.
02
Drugs
nalbuphinebupivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on TCTR20250108002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250108002.